{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:04:04Z","timestamp":1771538644780,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["P01 AI165077"],"award-info":[{"award-number":["P01 AI165077"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"DOI":"10.1038\/s44298-026-00179-4","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:36:03Z","timestamp":1771490163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenicity and protective efficacy of MERS CoV, NL140422, and HKU4 spike protein nanoparticle vaccines"],"prefix":"10.1038","volume":"4","author":[{"given":"Peter J.","family":"Halfmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi S.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"179_CR1","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki, A. M., Boheemen, S. V., Bestebroer, T. M., Osterhaus, A. D. M. E. & Fouchier, R. A. M. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814\u20131820 (2012).","journal-title":"N. Engl. J. Med."},{"key":"179_CR2","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881800345X","volume":"147","author":"RS Sikkema","year":"2019","unstructured":"Sikkema, R. S. et al. Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review. Epidemiol. Infect. 147, e84 (2019).","journal-title":"Epidemiol. Infect."},{"key":"179_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","volume":"20","author":"PM Folegatti","year":"2020","unstructured":"Folegatti, P. M. et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect. Dis. 20, 816\u2013826 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"179_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","volume":"20","author":"T Koch","year":"2020","unstructured":"Koch, T. et al. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Lancet Infect. Dis. 20, 827\u2013838 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"179_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","volume":"19","author":"K Modjarrad","year":"2019","unstructured":"Modjarrad, K. et al. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. Lancet Infect. Dis. 19, 1013\u20131022 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"179_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/cmi.2015.03","volume":"13","author":"N Zhang","year":"2016","unstructured":"Zhang, N. et al. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. Cell. Mol. Immunol. 13, 180\u2013190 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"179_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/21645515.2017.1296994","volume":"13","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection. Hum. Vaccines Immunotherapeutics 13, 1615\u20131624 (2017).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"179_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.virol.2016.10.005","volume":"499","author":"W Tai","year":"2016","unstructured":"Tai, W. et al. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection. Virology 499, 375\u2013382 (2016).","journal-title":"Virology"},{"key":"179_CR9","doi-asserted-by":"publisher","first-page":"e01651","DOI":"10.1128\/JVI.01651-16","volume":"91","author":"W Tai","year":"2017","unstructured":"Tai, W. et al. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants. J. Virol. 91, e01651\u201301616 (2017).","journal-title":"J. Virol."},{"key":"179_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","volume":"182","author":"L Dai","year":"2020","unstructured":"Dai, L. et al. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Cell 182, 722\u2013733.e711 (2020).","journal-title":"Cell"},{"key":"179_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.antiviral.2016.12.019","volume":"140","author":"C Wang","year":"2017","unstructured":"Wang, C. et al. Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice. Antivir. Res. 140, 55\u201361 (2017).","journal-title":"Antivir. Res."},{"key":"179_CR12","doi-asserted-by":"crossref","unstructured":"Kim, Y.-S. et al. Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles. Front. Immunol. 9 - 2018 (2018).","DOI":"10.3389\/fimmu.2018.01093"},{"key":"179_CR13","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1080\/22221751.2020.1760735","volume":"9","author":"NMA Okba","year":"2020","unstructured":"Okba, N. M. A. et al. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV. Emerg. Microbes Infect. 9, 1080\u20131091 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"179_CR14","doi-asserted-by":"publisher","unstructured":"Chao, C. W. et al. Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV. Cell Reports 43, https:\/\/doi.org\/10.1016\/j.celrep.2024.115036 (2024).","DOI":"10.1016\/j.celrep.2024.115036"},{"key":"179_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201807616","volume":"29","author":"LC-W Lin","year":"2019","unstructured":"Lin, L. C.-W. et al. Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus. Adv. Funct. Mater. 29, 1807616 (2019).","journal-title":"Adv. Funct. Mater."},{"key":"179_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/vaccines7020046","volume":"7","author":"MM Shehata","year":"2019","unstructured":"Shehata, M. M. et al. Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV. Vaccines 7, 46 (2019).","journal-title":"Vaccines"},{"key":"179_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2346390","volume":"20","author":"I Almansour","year":"2024","unstructured":"Almansour, I. & Jermy, B. R. Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV. Hum. Vaccines Immunotherapeutics 20, 2346390 (2024).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"179_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2023.199156","volume":"334","author":"W Tai","year":"2023","unstructured":"Tai, W. et al. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection. Virus Res. 334, 199156 (2023).","journal-title":"Virus Res."},{"key":"179_CR19","doi-asserted-by":"publisher","first-page":"e01107","DOI":"10.1128\/mbio.01107-25","volume":"16","author":"L Shi","year":"2025","unstructured":"Shi, L. et al. A single-dose intranasal immunization with a novel bat influenza A virus-vectored MERS vaccine provides effective protection against lethal MERS-CoV challenge. mBio 16, e01107\u2013e01125 (2025).","journal-title":"mBio"},{"key":"179_CR20","doi-asserted-by":"publisher","unstructured":"Menachery, V. D. et al. Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection. J. Virol. 94, https:\/\/doi.org\/10.1128\/JVI.01774-19 (2020).","DOI":"10.1128\/JVI.01774-19"},{"key":"179_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/infdis\/jiy018","volume":"218","author":"SKP Lau","year":"2018","unstructured":"Lau, S. K. P. et al. Receptor Usage of a Novel Bat Lineage C Betacoronavirus Reveals Evolution of Middle East Respiratory Syndrome-Related Coronavirus Spike Proteins for Human Dipeptidyl Peptidase 4 Binding. J. Infect. Dis. 218, 197\u2013207 (2018).","journal-title":"J. Infect. Dis."},{"key":"179_CR22","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.cell.2024.12.032","volume":"188","author":"Y-J Park","year":"2025","unstructured":"Park, Y.-J. et al. Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses. Cell 188, 1711\u20131728.e1721 (2025).","journal-title":"Cell"},{"key":"179_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41586-022-05513-3","volume":"612","author":"Q Xiong","year":"2022","unstructured":"Xiong, Q. et al. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors. Nature 612, 748\u2013757 (2022).","journal-title":"Nature"},{"key":"179_CR24","doi-asserted-by":"publisher","first-page":"00116","DOI":"10.1128\/JVI.00116-18","volume":"92","author":"C-M Luo","year":"2018","unstructured":"Luo, C.-M. et al. Discovery of Novel Bat Coronaviruses in South China That Use the Same Receptor as Middle East Respiratory Syndrome Coronavirus. J. Virol. 92, 00116\u201300118 (2018).","journal-title":"J. Virol."},{"key":"179_CR25","doi-asserted-by":"crossref","unstructured":"Tse, L. V. et al. A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus. Sci. Transl. Med. 15, eadg5567 (2023).","DOI":"10.1126\/scitranslmed.adg5567"},{"key":"179_CR26","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.cell.2023.01.019","volume":"186","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry. Cell 186, 850\u2013863.e816 (2023).","journal-title":"Cell"},{"key":"179_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45453-2","volume":"15","author":"LY Xia","year":"2024","unstructured":"Xia, L. Y. et al. Isolation and characterization of a pangolin-borne HKU4-related coronavirus that potentially infects human-DPP4-transgenic mice. Nat. Commun. 15, 1048 (2024).","journal-title":"Nat. Commun."},{"key":"179_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20458-9","volume":"12","author":"SKP Lau","year":"2021","unstructured":"Lau, S. K. P. et al. Isolation of MERS-related coronavirus from lesser bamboo bats that uses DPP4 and infects human-DPP4-transgenic mice. Nat. Commun. 12, 216 (2021).","journal-title":"Nat. Commun."},{"key":"179_CR29","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.1073\/pnas.1405889111","volume":"111","author":"Y Yang","year":"2014","unstructured":"Yang, Y. et al. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc. Natl. Acad. Sci. USA 111, 12516\u201312521 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"179_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","volume":"16","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16, 328\u2013337 (2014).","journal-title":"Cell Host Microbe"},{"key":"179_CR31","doi-asserted-by":"publisher","unstructured":"Hsieh, C.-L. et al. Stabilized coronavirus spike stem elicits a broadly protective antibody. Cell Reports 37, https:\/\/doi.org\/10.1016\/j.celrep.2021.109929 (2021).","DOI":"10.1016\/j.celrep.2021.109929"},{"key":"179_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s44298-025-00142-9","volume":"3","author":"PJ Halfmann","year":"2025","unstructured":"Halfmann, P. J. et al. Merbecovirus S2 subunit vaccines elicit cross reactive antibodies and provide partial protection against MERS coronavirus. npj Viruses 3, 60 (2025).","journal-title":"npj Viruses"},{"key":"179_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s42003-021-02128-8","volume":"4","author":"S Chiba","year":"2021","unstructured":"Chiba, S. et al. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization. Commun. Biol. 4, 597 (2021).","journal-title":"Commun. Biol."},{"key":"179_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55824-y","volume":"16","author":"PJ Halfmann","year":"2025","unstructured":"Halfmann, P. J. et al. Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice. Nat. Commun. 16, 462 (2025).","journal-title":"Nat. Commun."},{"key":"179_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45495-6","volume":"15","author":"PJ Halfmann","year":"2024","unstructured":"Halfmann, P. J. et al. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine. Nat. Commun. 15, 1284 (2024).","journal-title":"Nat. Commun."},{"key":"179_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104341","volume":"86","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann, P. J. et al. Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses. eBioMedicine 86, 104341 (2022).","journal-title":"eBioMedicine"},{"key":"179_CR37","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.4049\/jimmunol.172.4.2453","volume":"172","author":"ACM Boon","year":"2004","unstructured":"Boon, A. C. M. et al. Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes1. J. Immunol. 172, 2453\u20132460 (2004).","journal-title":"J. Immunol."},{"key":"179_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.226","volume":"2","author":"AS Cockrell","year":"2016","unstructured":"Cockrell, A. S. et al. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat. Microbiol 2, 16226 (2016).","journal-title":"Nat. Microbiol"},{"key":"179_CR39","first-page":"E3119","volume":"114","author":"K Li","year":"2017","unstructured":"Li, K. et al. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc. Natl. Acad. Sci. 114, E3119\u2013E3128 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"179_CR40","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1093\/infdis\/jiad612","volume":"230","author":"CE Harrer","year":"2024","unstructured":"Harrer, C. E. et al. Identification of a Spike-Specific CD8+ T-Cell Epitope Following Vaccination Against the Middle East Respiratory Syndrome Coronavirus in Humans. J. Infect. Dis. 230, e327\u2013e332 (2024).","journal-title":"J. Infect. Dis."},{"key":"179_CR41","doi-asserted-by":"publisher","unstructured":"Weskamm, L. M. et al. Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach. iScience 27, https:\/\/doi.org\/10.1016\/j.isci.2024.110470 (2024).","DOI":"10.1016\/j.isci.2024.110470"},{"key":"179_CR42","doi-asserted-by":"publisher","unstructured":"Sch\u00e4fer, A. et al. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. J. Exp. Med. 218, https:\/\/doi.org\/10.1084\/jem.20201993 (2021).","DOI":"10.1084\/jem.20201993"},{"key":"179_CR43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41564-023-01359-1","volume":"8","author":"SR Mackin","year":"2023","unstructured":"Mackin, S. R. et al. Fc-\u03b3R-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2. Nat. Microbiol 8, 569\u2013580 (2023).","journal-title":"Nat. Microbiol"},{"key":"179_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq7647","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques. Sci. Immunol. 7, eabq7647 (2022).","journal-title":"Sci. Immunol."},{"key":"179_CR45","doi-asserted-by":"publisher","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","volume":"114","author":"J Pallesen","year":"2017","unstructured":"Pallesen, J. et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl. Acad. Sci. 114, E7348\u2013E7357 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"179_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jmb.2013.09.016","volume":"426","author":"M Fairhead","year":"2014","unstructured":"Fairhead, M., Krndija, D., Lowe, E. D. & Howarth, M. Plug-and-play pairing via defined divalent streptavidins. J. Mol. Biol. 426, 199\u2013214 (2014).","journal-title":"J. Mol. Biol."},{"key":"179_CR47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371\u2013376 (2004).","journal-title":"Science"}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00179-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T21:03:24Z","timestamp":1771535004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00179-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1038\/s44298-026-00179-4","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}